{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:38:47Z","timestamp":1793277527811,"version":"4.5.0"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:p>Procalcitonin is a well-established biomarker of bacterial infections in human medicine, used to guide initiation and duration of antimicrobial treatment. C-reactive protein (CRP) is a frequently used marker of inflammation in dogs, but is not specific for bacterial infection. The main objective of this study was to determine kinetics of plasma PCT (pPCT) and CRP in dogs with sepsis, non-infectious systemic inflammatory response syndrome (nSIRS) and healthy dogs. This prospective, observational study included 17 dogs with sepsis, 16 with nSIRS and 15 healthy dogs. Hematologic parameters, pPCT and CRP were assessed on days 1, 2 and 3 in healthy dogs and on days 1, 2, 3 and 4 in dogs with nSIRS or sepsis. The shortened Acute Patient Physiologic and Laboratory Evaluation (APPLE<jats:sub>fast<\/jats:sub>) score was calculated for dogs with sepsis and nSIRS. Plasma PCT was measured using a validated canine PCT ELISA. There was no significant difference in median pPCT between healthy dogs (110.3\u202fpg\/mL; IQR 74.7\u2013138) and dogs with sepsis (81.6\u202fpg\/mL; IQR 50.1\u2013157.1) or nSIRS (105.3\u202fpg\/mL; IQR 87.6\u2013164.7). Prior antimicrobial treatment was not associated with a decrease in pPCT concentration in septic dogs. In the sepsis group, day 1 pPCT concentrations were significantly higher in non-survivors than in survivors (<jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.05). In contrast, median CRP was above the reference range (&amp;lt;10.5\u202fmg\/L) in dogs with nSIRS (100.7\u202fmg\/L; IQR 67\u2013141.9) or sepsis (131.9\u202fmg\/L; IQR 75.7\u2013194.8) and significantly decreased within the first 4\u202fdays of successful antimicrobial treatment of sepsis. In conclusion, while plasma PCT showed some prognostic value, it was not a useful biomarker for assessing the efficacy of the chosen antimicrobial treatment in dogs with sepsis.<\/jats:p>","DOI":"10.3389\/fvets.2025.1609020","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T04:16:40Z","timestamp":1750220200000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Plasma procalcitonin and C-reactive protein concentrations in dogs with bacterial sepsis and non-infectious systemic inflammatory response syndrome"],"prefix":"10.3389","volume":"12","author":[{"given":"Johanna","family":"Rompf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9r\u00e9nice","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja-Nicole","family":"Adamik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliane","family":"Marti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Mirkovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laureen Mich\u00e8le","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Eiermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gertraud","family":"Sch\u00fcpbach-Regula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Hettlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Willi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Schuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,18]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1080\/10408398.2015.1077192","article-title":"Antimicrobial resistance: a global emerging threat to public health systems","volume":"57","author":"Ferri","year":"2017","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.mcna.2018.04.005","article-title":"Antimicrobial resistance: an antimicrobial\/diagnostic stewardship and infection prevention approach","volume":"102","author":"Septimus","year":"2018","journal-title":"Med Clin North Am"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s12325-020-01558-w","article-title":"Antimicrobial stewardship in the intensive care unit: the role of biomarkers, pharmacokinetics, and pharmacodynamics","volume":"38","author":"Moniz","year":"2021","journal-title":"Adv Ther"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s15006-021-9959-7","article-title":"Procalcitonin (PCT)","volume":"163","author":"Laborparameter","year":"2021","journal-title":"MMW Fortschr Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ccc.2019.08.003","article-title":"Procalcitonin: where are we now?","volume":"36","author":"Hamade","year":"2020","journal-title":"Crit Care Clin"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0140-6736(09)61879-1","article-title":"Use of procalcitonin to reduce patients\u2019 exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial","volume":"375","author":"Bouadma","year":"2010","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cca.2019.06.010","article-title":"Procalcitonin: between evidence and critical issues","volume":"496","author":"Aloisio","year":"2019","journal-title":"Clin Chim Acta"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1089\/sur.2012.028","article-title":"The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?","volume":"14","author":"Sridharan","year":"2013","journal-title":"Surg Infect"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e000255","DOI":"10.1136\/vetreco-2017-000255","article-title":"Plasma procalcitonin concentrations are increased in dogs with sepsis","volume":"5","author":"Goggs","year":"2018","journal-title":"Vet Rec Open"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.14943\/jjvr.69.1.5","article-title":"Can procalcitonin be used as a clinical biomarker during bacterial, viral and parasitic infections in dogs?","volume":"69","author":"Matur","year":"2021","journal-title":"Jpn J Vet Res"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/jvim.15711","article-title":"Serum procalcitonin concentrations in dogs with induced endotoxemia","volume":"34","author":"Easley","year":"2020","journal-title":"J Vet Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12917-018-1427-y","article-title":"Plasma procalcitonin concentrations predict organ dysfunction and outcome in dogs with sepsis","volume":"14","author":"Troia","year":"2018","journal-title":"BMC Vet Res"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1532-950X.1997.tb01699.x","article-title":"Evaluation of the sensitivity and specificity of diagnostic criteria for sepsis in dogs","volume":"26","author":"Hauptman","year":"1997","journal-title":"Vet Surg"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3390\/ani10091511","article-title":"Procalcitonin detection in veterinary species: investigation of commercial elisa kits","volume":"10","author":"Battaglia","year":"2020","journal-title":"Animals"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/vcp.13212","article-title":"Plasma procalcitonin kinetics in healthy dogs and dogs undergoing tibial plateau leveling osteotomy","volume":"52","author":"Rompf","year":"2023","journal-title":"Vet Clin Pathol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12917-017-1065-9","article-title":"Evaluation of a species-specific C-reactive protein assay for the dog on the ABX Pentra 400 clinical chemistry analyzer","volume":"13","author":"Hindenberg","year":"2017","journal-title":"BMC Vet Res"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3389\/fvets.2019.00208","article-title":"Biomarker guided diagnosis of septic peritonitis in dogs","volume":"6","author":"Martiny","year":"2019","journal-title":"Front Vet Sci"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/jvim.16374","article-title":"Serial analysis of blood biomarker concentrations in dogs with pneumonia, septic peritonitis, and pyometra","volume":"36","author":"Goggs","year":"2022","journal-title":"J Vet Intern Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1515\/CCLM.2004.077","article-title":"Multicenter evaluation of a new immunoassay for procalcitonin measurement on the Kryptor system","volume":"42","author":"Steinbach","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e0252206","DOI":"10.1371\/journal.pone.0252206","article-title":"Evaluation of leukopenia during sepsis as a marker of sepsis-defining organ dysfunction","volume":"16","author":"Belok","year":"2021","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/j.1476-4431.2009.00462.x","article-title":"Use of C-reactive protein to predict outcome in dogs with systemic inflammatory response syndrome or sepsis","volume":"19","author":"Gebhardt","year":"2009","journal-title":"J Vet Emerg Crit Care"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"R169","DOI":"10.1186\/cc10313","article-title":"C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study","volume":"15","author":"P\u00f3voa","year":"2011","journal-title":"Crit Care"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s13054-020-02993-5","article-title":"Biomarkers of sepsis: time for a reappraisal","volume":"24","author":"Pierrakos","year":"2020","journal-title":"Crit Care"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1177\/1040638720960065","article-title":"Evaluation of an automated immunoturbidimetric assay for detecting canine C-reactive protein","volume":"32","author":"Berlanda","year":"2020","journal-title":"J Vet Diagn Invest"}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2025.1609020\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T04:16:42Z","timestamp":1750220202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2025.1609020\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":24,"alternative-id":["10.3389\/fvets.2025.1609020"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2025.1609020","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,18]]},"article-number":"1609020"}}